{Reference Type}: Journal Article
{Title}: Liquid chromatography-tandem mass spectrometry in clinical laboratory protein measurement.
{Author}: Ma Y;Wang D;Li H;Ma X;Zou Y;Mu D;Yu S;Cheng X;Qiu L;
{Journal}: Clin Chim Acta
{Volume}: 562
{Issue}: 0
{Year}: 2024 Aug 15
{Factor}: 6.314
{DOI}: 10.1016/j.cca.2024.119846
{Abstract}: Proteins are essential components of human cells and tissues, and they are commonly measured in clinical laboratories using immunoassays. However, these assays have certain limitations, such as non-specificity binding, insufficient selectivity, and interference of antibodies. More sensitive, accurate, and efficient technology is required to overcome these limitations. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is a powerful analytical tool that provides high sensitivity and specificity, making it superior to traditional methods such as biochemical methods and immunoassays. While LC-MS/MS has been increasingly used for detecting small molecular analytes and steroid hormones in clinical practice recently, its application for protein or peptide analysis is still in its early stages. Established methods for quantifying proteins and peptides by LC-MS/MS are mainly focused on scientific research, and only a few proteins and peptides can be or have the potential to be detected and applied in clinical practice. Therefore, this article aims to review the clinical applications, advantages, and challenges of analyzing proteins and peptides using LC-MS/MS in clinical laboratories.